Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Fragile X Syndrome

Interventions

DRUG

AFQ056

Trial Locations (4)

Novartis Investigative Site, Chicago

Novartis Investigative Site, Sacramento

Novartis Investigative Site, Nashville

Novartis Investigative Site, Sant Cugat del Vallès